Selected Publications

Nagarkatte M, Kastl A, Kappelman MD et al.: Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in VEO-IBD. NASPGHAN 2023 Conference, poster presentation November 2023.

Zong W, Salich J, Kastl A, Kirsch J, Albenberg L, Bales C: Whole food introduction associated with symptomatic anastomotic ulceration in children with short bowel syndrome. Journal of Pediatric Gastroenterology, Hepatology, and Nutrition September 2023.

Zong W, Kastl A, Bales C et al.: Whole foods introduction associated with symptomatic anastomotic ulceration in children with short bowel syndrome. DDW 2023 Conference, poster presentation May 2023.

Kastl A, Weaver KN, Zhang X, Strople JA, Adler J, Dubinsky MC, Bousvaros A, Watkins R, Dai X, Cross RK, Higgins PDR, Ungaro R, Bewtra M, Bellaguarda E, Farraye FA, Chun K, Zikry M, Fernando M, Bastidas M, Hernandez CG, Craig RG, Boccieri ME, Firestine A, Long MD, Kappelman MD.: Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease. American Journal of Gastroenterology January 2023.

Kastl A, Zong W, Gershuni V, Friedman ES, Tanes C, Boateng A, Mitchell WJ, O'Connor K, Bittinger K, Terry N, Bales C, Albenberg L, Wu GD.: Clinical Phenotyping of Patients with Short Bowel Syndrome Via Effects of Diet and the Gut Microbiota on Bile Acid Metabolism. NASPGHAN 2022 Annual Meeting October 2022 Notes: Poster Presentation.

Kastl A, Weaver KN, Zhang X, Strople JA, Adler J, Dubinsky MC, Bousvaros A, Watkins R, Dai X, Cross RK, Higgins PDR, Ungaro R, Bewtra M, Bellaguarda E, Farraye FA, Chun K, Zikry M, Fernando M, Bastidas M, Hernandez CG, Craig RG, Boccieri ME, Firestine A, Long MD, Kappelman MD.: Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease. NASPGHAN 2022 Annual Meeting October 2022 Notes: Poster Presentation.

Long MD, Weaver KN, Zhang X, Chun K, Kastl A, Kappelman MD; PREVENT-COVID Study Group: Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients with Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 20(8): 1881-1883, August 2022.

Weaver, KN, Zhang X, Dai X, Chen W, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda E, Farrays FA, Craig R, Hernandez C, Boccieri ME, Firestine A, Chun KY, Long MD, Kappelman MD.: Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Disease July 2022.

Kappelman MD, Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda E, Farraye FA, Boccieri ME, Firestine A, Chun KY, Fernando M, Bastidas M, Zikry M, Long MD: Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients with Inflammatory Bowel Disease. American Journal of Gastroenterology 117(3): 462-469, March 2022.

Kastl A, Zong W, Gershuni VM, Friedman ES, Tanes C, Boateng A, Mitchell WJ, O'Connor K, Bittinger K, Terry NA, Bales C, Albenberg L, Wu GD.: Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease. Gut Microbes 14(1), January 2022.